Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation

Journal of Clinical Pathology

Volumn 65, Issue 2, 2012, Pages 171-177

  Borel, Nicole ^a   Pospischil, Andreas ^a   Dowling, Robert D ^b   Dumrese, Claudia ^a   Gaydos, Charlotte A ^c   Bunk, Sebastian ^d   Hermann, Corinna ^d   Ramirez, Julio A ^b   Summersgill, James T ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Louisville School of Medicine   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIUM ANTIBODY; VIRULENCE FACTOR;

ADULT; ARTICLE; ATHEROMA; CARDIAC PATIENT; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HEART; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERVENTION STUDY; ISCHEMIC CARDIOMYOPATHY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TISSUE SECTION;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CORONARY VESSELS; DNA, VIRAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART TRANSPLANTATION; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84856086135     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200270     Document Type: Article

References (27)

1. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-63.
2. Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8. (Pubitemid 16097964)
3. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-82.
4. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
5. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002;288:2724-31. (Pubitemid 35403786)
6. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010;(201 Suppl 2):S88-95.
7. Hogan RJ, Mathews SA, Mukhopadhyay S, et al. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004;72:1843-55. (Pubitemid 38419894)
8. Pospischil A, Borel N, Chowdhury E, et al. Aberrant chlamydia developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis. Vet Microbiol 2009;135:147-56.
9. Borel N, Mukhopadhyay S, Kaiser C, et al. Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis 2006;6:152-6.
10. Borel N, Summersgill JT, Mukhopadhyay S, et al. Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas. Atherosclerosis 2008;199:154-61. (Pubitemid 351842691)
11. Huston WM, Therodoropoulos C, Matthews S, et al. Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of extracytoplasmic stress response protease HtrA. BMC Microbiol 2008;8:190.
12. Luo J, Jia T, Zhong Y, et al. Localization of the hypothetical protein Cpn0585 in the inclusion membrane of Chlamydia pneumoniae-infected cells. Microb Pathog 2007;42:111-16. (Pubitemid 46283327)
13. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organism. Int J Syst Bacteriol 1999;49:415-40.
14. Ehricht R, Slickers P, Goellner S, et al. Optimized DNA microarray assay allows detection and genotyping of single PCR-amplifiable target copies. Mol Cell Probes 2006;20:60-3. (Pubitemid 43254877)
15. Ramachandran P, Agreda P, Gaydos CA. Rapid Identification of any Chlamydia sp. Through Multi Probe Real-time Polymerase Chain Reaction (PCR) and High Resolution Melt Curve Analysis (HRMA) Using 16S rRNA as the Target. Abst #C-141; 17-21 May 2009, Philadelphia, PA: American Society for Microbiology.
16. Bunk S, Susnea I, Summersgill JT, et al. Immunoproteomic identification and serological response to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J Immunol 2008;80:5490-8.
17. Bunk S, Schaffert H, Schmid B, et al. Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns. Clin Vaccine Immunol 2010;217:705-12.
18. Meijer A, Roholl PJ, Gielis-Proper SK, et al. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J Clin Pathol 2000;52:911-16.
19. Meijer A, Roholl PJ, Gielis-Proper SK, et al. Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods. J Clin Pathol 2000;53:904-10.
20. Molestina RE, Klein JB, Miller RD, et al. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 2002;70:2976-81. (Pubitemid 34564156)
21. Mukhopadhyay S, Miller RD, Sullivan ED, et al. Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun 2006;74:3853-63. (Pubitemid 43993316)
22. Paschen SA, Christian JG, Vier J, et al. Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease. J Cell Biol 2008;182:117-27. (Pubitemid 352008626)
23. Heuer D, Brinkmann V, Meyer TF, et al. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 2003;5: 315-22. (Pubitemid 37009909)
24. Sharma J, Bosnic AM, Piper JM, et al. Human antibody responses to a Chlamydiasecreted protease factor. Infect Immun 2004;72:7164-71. (Pubitemid 39552387)
25. Kawana K, Quayle AJ, Ficarra M, et al. CD1d degradation in Chlamydia trachomatisinfected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem 2007;282:7368-75. (Pubitemid 47093705)
26. Huston WM, Swedberg JE, Harris JM, et al. The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C. FEBS Lett 2007;581:3382-6. (Pubitemid 47048181)
27. Peters J, Wilson DP, Myers G, et al. Type III secretion system à la Chlamydia. Trends Microbiol 2007;6:241-51. (Pubitemid 46856166)